Plexus (NASDAQ: PLXS) has recently received a number of price target changes and ratings updates: 11/2/2026 – Plexus was upgraded by Fox Advisors from “equal weight” to “overweight”. 11/1/2026 – Plexus was upgraded by Wall Street Zen from “hold” to “buy”. 10/24/2026 – Plexus was downgraded by Wall Street Zen from “buy” to “hold”. 10/23/2026 […]

A number of research firms have changed their ratings and price targets for Proto Labs (NYSE: PRLB): 11/2/2026 – Proto Labs had its “market perform” rating reaffirmed by William Blair. 10/27/2026 – Proto Labs had its “overweight” rating reaffirmed by Cantor Fitzgerald. 10/23/2026 – Proto Labs had its price target raised by Needham & Company […]

A number of firms have modified their ratings and price targets on shares of Dave (NASDAQ: DAVE) recently: 10/31/2026 – Dave was downgraded by Wall Street Zen from “hold” to “sell”. 10/30/2026 – Dave was downgraded by Weiss Ratings from “buy (b)” to “buy (b-)”. 10/26/2026 – Dave is now covered by Monness Crespi & […]